Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simron Singh

Showing results (31-40 of 141) with videos related to

Pageof 15
Sort By:
CMAJ Open|November 9, 2018
Screening for a new primary cancer in patients with existing metastatic cancer: a retrospective cohort studyMatthew C Cheung, Jill Tinmouth, Peter C Austin, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 3, 2012
A systematic review of patient surveillance after curative gastrectomy for gastric cancer: a brief reviewRoberta Cardoso, Natalie G Coburn, Rajini Seevaratnam, et al.
Surgical Oncology Clinics of North America|November 28, 2016
Uncommon Anal NeoplasmsAmitesh C Roy, David Wattchow, David Astill, et al.
Endocrine Oncology (Bristol, England)|August 7, 2024
Tolerability and outcomes of neuroendocrine tumors treated with PRRT and SBRTJose E Nunez, Sylvia Ng, Hanbo Chen, et al.
Journal of Oncology Practice|October 16, 2014
Quality improvement: an assessment of participation and attitudes of medical oncologistsCharles Lim, Matthew C Cheung, Bryan Franco, et al.
Annals of Surgical Oncology|September 13, 2025
Contemporary Short-Term Outcomes of Liver-Directed Therapy for Neuroendocrine Tumor Liver MetastasesLéamarie Meloche-Dumas, Frédéric Mercier, Simron Singh, et al.
Cancer|April 1, 2015
Rural-urban disparities in incidence and outcomes of neuroendocrine tumors: A population-based analysis of 6271 casesJulie Hallet, Calvin H L Law, Paul J Karanicolas, et al.
Virchows Archiv : an International Journal of Pathology|April 17, 2013
Ki-67 is a reliable pathological grading marker for neuroendocrine tumorsAshlie Nadler, Moises Cukier, Corwyn Rowsell, et al.
Endocrine-Related Cancer|May 15, 2023
Second primary cancers and survival among neuroendocrine tumor patientsSarah B Bateni, Natalie G Coburn, Calvin Law, et al.
Journal of Patient Experience|September 6, 2021
Cancer Treatment During COVID-19: A Qualitative Analysis of Patient-Perceived Risks and Experiences with Virtual CareGotlib Conn Lesley, Houman Tahmasebi, Nicholas Meti, et al.
Pageof 15

Showing results (31-40 of 141) with videos related to

Sort By:
Pageof 15
CMAJ Open|November 9, 2018
Screening for a new primary cancer in patients with existing metastatic cancer: a retrospective cohort studyMatthew C Cheung, Jill Tinmouth, Peter C Austin, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 3, 2012
A systematic review of patient surveillance after curative gastrectomy for gastric cancer: a brief reviewRoberta Cardoso, Natalie G Coburn, Rajini Seevaratnam, et al.
Surgical Oncology Clinics of North America|November 28, 2016
Uncommon Anal NeoplasmsAmitesh C Roy, David Wattchow, David Astill, et al.
Endocrine Oncology (Bristol, England)|August 7, 2024
Tolerability and outcomes of neuroendocrine tumors treated with PRRT and SBRTJose E Nunez, Sylvia Ng, Hanbo Chen, et al.
Journal of Oncology Practice|October 16, 2014
Quality improvement: an assessment of participation and attitudes of medical oncologistsCharles Lim, Matthew C Cheung, Bryan Franco, et al.
Annals of Surgical Oncology|September 13, 2025
Contemporary Short-Term Outcomes of Liver-Directed Therapy for Neuroendocrine Tumor Liver MetastasesLéamarie Meloche-Dumas, Frédéric Mercier, Simron Singh, et al.
Cancer|April 1, 2015
Rural-urban disparities in incidence and outcomes of neuroendocrine tumors: A population-based analysis of 6271 casesJulie Hallet, Calvin H L Law, Paul J Karanicolas, et al.
Virchows Archiv : an International Journal of Pathology|April 17, 2013
Ki-67 is a reliable pathological grading marker for neuroendocrine tumorsAshlie Nadler, Moises Cukier, Corwyn Rowsell, et al.
Endocrine-Related Cancer|May 15, 2023
Second primary cancers and survival among neuroendocrine tumor patientsSarah B Bateni, Natalie G Coburn, Calvin Law, et al.
Journal of Patient Experience|September 6, 2021
Cancer Treatment During COVID-19: A Qualitative Analysis of Patient-Perceived Risks and Experiences with Virtual CareGotlib Conn Lesley, Houman Tahmasebi, Nicholas Meti, et al.
Pageof 15